Symbol: |
MARVELD2
|
Description: |
MARVEL domain containing 2 [Source:HGNC Symbol;Acc:26401]
|
Location: |
Chr5:68710939-68740157[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:154
Gene |
Compound |
Gen_sig |
Exp_pattern |
MARVELD2 |
MYCOTRIENINE-LIKE |
0.043 |
Up |
MARVELD2 |
NSC 49692 |
0.027 |
Down |
MARVELD2 |
C.I. 37559 |
0.002 |
Up |
MARVELD2 |
NSC 527353 |
0.035 |
Down |
MARVELD2 |
NSC 58903 |
0.017 |
Up |
MARVELD2 |
Camptothecin ethylglycinate ester hydrochloride |
0.005 |
Up |
MARVELD2 |
Camptothecin hemisuccinate sodium salt |
0.018 |
Up |
MARVELD2 |
Camptothecin lysinate HCl |
0.026 |
Up |
MARVELD2 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.001 |
Up |
MARVELD2 |
9-AMINO-20-CAMPTOTHECIN |
0.045 |
Up |
MARVELD2 |
L-Lysine, N-[(methylamino)carbonyl]-N'-(phenylmethoxy- carbonyl)-, phenylmethyl ester |
0.002 |
Up |
MARVELD2 |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.008 |
Up |
MARVELD2 |
1,4-BIS(DIETHYLAMINO)-5,8-DIHYDROXY ANTHRAQUINON |
0.017 |
Up |
MARVELD2 |
NSC 645364 |
0.032 |
Up |
MARVELD2 |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.02 |
Up |
Expression pattern: Sensitivity / Resistance
Total:11 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:2
SNP |
Gene |
SNP_location |
SNP_allele |
rs142001621 |
MARVELD2 |
Chr5:68737747 |
T/A |
rs192412701 |
MARVELD2 |
Chr5:68737815 |
C/T |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:74
Gene |
Gen_transcript |
miRNA |
miR_location |
MARVELD2 |
ENST00000325631 |
hsa-let-7a-5p |
Chr11:122017276-122017297[-] |
MARVELD2 |
ENST00000325631 |
hsa-let-7a-5p |
Chr22:46508632-46508653[+] |
MARVELD2 |
ENST00000325631 |
hsa-let-7a-5p |
Chr9:96938244-96938265[+] |
MARVELD2 |
ENST00000325631 |
hsa-let-7d-5p |
Chr9:96941123-96941144[+] |
MARVELD2 |
ENST00000325631 |
hsa-let-7f-5p |
Chr9:96938635-96938656[+] |
MARVELD2 |
ENST00000325631 |
hsa-let-7f-5p |
ChrX:53584207-53584228[-] |
MARVELD2 |
ENST00000282886 |
hsa-mir-10a-3p |
Chr17:46657226-46657247[-] |
MARVELD2 |
ENST00000325631 |
hsa-mir-125b-1-3p |
Chr11:121970477-121970498[-] |
MARVELD2 |
ENST00000325631 |
hsa-mir-140-3p |
Chr16:69967045-69967065[+] |
MARVELD2 |
ENST00000325631 |
hsa-mir-140-5p |
Chr16:69967006-69967027[+] |
MARVELD2 |
ENST00000325631 |
hsa-mir-152 |
Chr17:46114540-46114560[-] |
MARVELD2 |
ENST00000325631 |
hsa-mir-194-5p |
Chr11:64658876-64658897[-] |
MARVELD2 |
ENST00000325631 |
hsa-mir-194-5p |
Chr1:220291548-220291569[-] |
MARVELD2 |
ENST00000325631 |
hsa-mir-196b-5p |
Chr7:27209147-27209168[-] |
MARVELD2 |
ENST00000282886 |
hsa-mir-200b-5p |
Chr1:1102504-1102525[+] |
Total:5 Current:1
[First] [Prev]  Next Last 
|